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Prolyl hydroxylases (PHDs) sense oxygen, regulate levels of hypoxia-inducible factors (HIFs), and permit hyp-
oxic adaptation. A new study by Aragones et al. (2008) demonstrates that mice lacking skeletal muscle PHD1
have decreased exercise tolerance and oxygen consumption but remarkably tolerate ischemia in a HIF-2a-
and PPARa-dependent fashion.Cell Metabolism 7, March 2008 ª2008 Elsevier Inc. 191Living with oxygen bears a price of the
toxic effects of mitochondrially produced
reactive oxygen species (ROS). ROS
damage macromolecules and oxidize
metal ions. Paradoxically, oxygen deple-
tion (hypoxia) also increases mitochon-
drial ROS that are detrimental to cells un-
less attenuated (Guzy and Schumacker,
2006). In this regard, cells adapt to hyp-
oxia through induction of the hypoxia-in-
ducible factor (HIF) family of transcription
factors. HIF-1 is ubiquitously expressed,
while HIF-2 has restricted tissue expres-
sion (Semenza, 2007). HIF-3 is the least
well-studied family member. The HIFs
consist of a constitutively expressed, sta-
ble HIFb subunit and an oxygen-sensitive
HIFa subunit, which is hydroxylated
through the use of oxygen by prolyl hy-
droxylases (PHDs) and is subsequently
destined for von Hippel-Lindau (VHL)-de-
pendent proteasomal degradation (Fig-
ure 1). In hypoxic conditions, increased
mitochondrial ROS oxidize the PHD cata-
lytic ferrous ion, rendering the enzyme in-
capable of hydroxylating HIFa. The non-
hydroxylated, stabilized HIFa subunit
heterodimerizes with HIFb and transacti-
vates genes that permit hypoxic adapta-
tion. A new study by Aragones et al.
(2008) shows that mice lacking skeletal
muscle PHD1 have decreased oxygen
consumption and impaired tolerance to
exercise but surprisingly are protected
from ischemia in a HIF-2a-dependent
fashion due to decreased mitochondrially
derived ROS.
A previously unsuspected mechanism
that controls mitochondrial ROS produc-
tion involves the transactivation of pyru-
vate dehydrogenase kinase 1 (PDK1) by
HIF-1 (Kim et al., 2006; Papandreou
et al., 2006). PDK1 is a member of a family
of proteins that phosphorylates and in-
activates pyruvate dehydrogenase (PDH),thereby diverting pyruvate from mito-
chondria and yielding lactate (Roche and
Hiromasa, 2007). This key gatekeeper
for pyruvate metabolism is essential for
hypoxic adaptation, such that diminished
PDK1 expression results in ROS-medi-
ated cell death (Figure 1).
Since PHDs are direct oxygen sensors,
depletion of PHDs by homologous re-
combination is expected to alter hypoxic
adaptation (Berra et al., 2006). PHD sub-
strates and tissue-specific effects are
only beginning to be defined. HIF-1a is
targeted by PHD2, which itself is induced
by hypoxia, as is PHD3. It is notable that
IkB kinase b is also targeted by PHD1, in-
dicating that the effects of PHDs are likely
to be multifaceted (Cummins et al., 2006).
Homologous recombination-mediated
knockout of PHDs has revealed that
PHD1 and PHD3 null animals are viable,
while homozygous deletion of PHD2 is
embryonically lethal (Takeda et al., 2006).
Aragones et al. (2008) report the effects
of PHD1 deletion on muscle function and
metabolism in mice. Muscle relies on fat
and glucose oxidation when oxygen is
ample. However, with prolonged exercise,
limitedcellular oxygen levels trigger glyco-
lytic carbohydrate metabolism, resulting
Figure 1. Role of PHD1 in Metabolism
Glucose is transported into the cytoplasm and further metabolized via glycolysis to pyruvate. Pyruvate is
either converted to lactate or metabolized by pyruvate dehydrogenase (PDH) to acetyl-CoA in the mito-
chondrion, resulting in reactive oxygen species (ROS) production. Pyruvate dehydrogenase kinase 4
(PDK4) phosphorylates and inhibits PDH, shunting pyruvate away from mitochondria. PHD1 hydroxylates
HIF-2 for proteasomal degradation. HIF-2 may transactivate PPARa, which in turn activates PDK4, which
may also be a direct target of HIF-2. Loss of PHD1 function is hence associated with elevated HIF-2,
PPARa, and PDK4.
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Previewsin lactate production. By contrast, adapta-
tion to hypoxia is quicker, with acute is-
chemia associated with arterial occlusion.
Because the activity of PHD is rapidly
modulated by oxygen levels, the identifi-
cation of PHD substrates and their activi-
ties is critical for our full understanding of
acute hypoxic adaptation. HIFs are cen-
tral PHD substrates, and as such, it is
thought that acute hypoxic muscle adap-
tation may involve HIFs.
Aragones et al. found that PHD1 null an-
imals appear grossly normal but have de-
creased exercise tolerance as compared
with wild-type controls. In particular,
PHD1 null skeletal myofibers have de-
creased oxygen consumption and in-
creased glycolysis, with fatty acid oxida-
tion comparable to control muscle. The
defect in respiration localizes to mito-
chondrial complex I, unassociated with
any changes in mitochondrial mass or
density. This contrasts with diminished
mitochondrial biogenesis associated
with increased HIFa, which is expected
with PHD1 deficiency, as reported in
VHL-deficient renal cancer cells (Zhang
et al., 2007). In addition, muscle-specific
deletion of HIF-1a improves oxidative ca-
pacity (Mason et al., 2007). As such, loss
of muscle PHD1 may affect HIF in a tis-
sue-specific manner, or perhaps the link
between HIF and mitochondrial biogene-
sis is more complex in vivo.
Remarkably, PHD1-deficient muscles
are resistant to ischemic necrosis trig-
gered by femoral artery ligation (Aragones
et al., 2008). PHD3 null or PHD2 heterozy-
gous muscles, however, are not pro-
tected, indicating a PHD1-specific effect.
In addition, ex vivo studies demonstrate
that PHD1-deficient myofibers consume
less oxygen and are more tolerant to hyp-
oxia as compared with control myofibers
that display apoptosis within 48 hours of
ischemia. Because PHD2 directly regu-
lates HIF-1a levels, these results suggest
that HIF-1 may not play a role in the ische-
mia-protective effect of diminished PHD1192 Cell Metabolism 7, March 2008 ª2008 Eexpression. In this regard, Aragones et al.
found that HIF-2a, but not HIF-1a, is in-
creased in hypoxic PHD1 null muscle.
Furthermore, heterozygous loss of HIF-2a
in PHD1-deficient muscles abrogated
hypoxic tolerance. These observations
suggest that HIF-2a is a downstream
effector of PHD1 in muscle.
Given that little is known about the dif-
ferent substrates for PHD1, how then
does PHD1 deficiency result in easily fa-
tigued muscles yet confer resistance to
hypoxic insult? It is possible that the de-
creased capacity for oxidative carbohy-
drate metabolism in PHD1-deficient mus-
cle compromises exercise endurance, as
seen in patients with mitochondrial DNA
defects. The resistance to ischemic ne-
crosis associated with PHD1 deficiency
may be linked to PHD-mediated regula-
tion of pyruvate flux and ROS production.
In fact, PHD1-deficient ischemic myofi-
bers contain much less oxidative DNA
modification as compared with control
myofibers (Aragones et al., 2008). De-
creased oxygen consumption is associ-
ated with elevated expression of HIF-2a,
PDK1, PPARa, and the PPARa target
PDK4. It remains to be determined
whether PPARa is a direct target for HIF,
as no consensus HIF sites have been
identified thus far in the PPARa proximal
promoter. Additionally, although Ara-
gones et al. (2008) demonstrate the de-
pendency of hypoxic tolerance on PPARa
by using RNA interference in PHD1-defi-
cient myofibers, the necessity of PDK4
was not shown. PDK4 expression, how-
ever, diminishes with PPARa knockdown,
suggesting that it is downstream of
PPARa. It is also possible that PDK1
may also play an important role, as en-
hanced oxidative capacity of HIF-1a-defi-
cient muscle is associated with dimin-
ished levels of PDK1, a HIF-1 target
(Mason et al., 2007). Furthermore, hetero-
zygous loss of HIF-1a in PHD1-deficient
muscles diminishes hypoxic tolerance,
though without reaching statistical signif-lsevier Inc.icance (Aragones et al., 2008). Finally,
whether PHD1 activation of NF-kB might
also affect the hypoxia-resistant pheno-
type of PHD1-deficient muscles remains
to be investigated (Cummins et al.,
2006). Further delineation of these path-
ways is important for our full understand-
ing of how oxygen sensing by PHDs regu-
lates muscle metabolism and whether
PDKs are critical proximal factors in regu-
lating the ROS response of ischemicmus-
cles. The Aragones et al. (2008) study
opens a new chapter on oxygen sensing
by PHDs and demonstrates how loss of
a specific PHD in vivo may lead to pro-
found effects on muscle metabolism.
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